Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy M Goodwin

Showing results (231-240 of 258) with videos related to

Pageof 26
Sort By:
The Journal of Clinical Psychiatry|November 19, 2008
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind studyMauricio Tohen, Eduard Vieta, Guy M Goodwin, et al.
The Lancet. Psychiatry|February 20, 2026
A digital imagery-competing task intervention for stopping intrusive memories in trauma-exposed health-care staff during the COVID-19 pandemic in the UK: a Bayesian adaptive randomised clinical trialAmy C Beckenstrom, Michael B Bonsall, Alfred Markham, et al.
Trials|March 4, 2016
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trialKate E A Saunders, Andrea Cipriani, Jennifer Rendell, et al.
Depression and Anxiety|July 30, 2020
Efficacy of digital cognitive behavioral therapy for moderate-to-severe symptoms of generalized anxiety disorder: A randomized controlled trialJenna R Carl, Christopher B Miller, Alasdair L Henry, et al.
Molecular Psychiatry|May 15, 2020
Patient fibroblast circadian rhythms predict lithium sensitivity in bipolar disorderHarshmeena R Sanghani, Aarti Jagannath, Thomas Humberstone, et al.
Bipolar Disorders|July 24, 2009
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disordersMauricio Tohen, Ellen Frank, Charles L Bowden, et al.
Trials|November 25, 2017
The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trialJonathan Kingslake, Rebecca Dias, Gerard R Dawson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 27, 2021
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trialMichael Browning, Amy C Bilderbeck, Rebecca Dias, et al.
Journal of Affective Disorders|March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Nature Reviews. Drug Discovery|February 2, 2012
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapyMark J Millan, Yves Agid, Martin Brüne, et al.
Pageof 26

Showing results (231-240 of 258) with videos related to

Sort By:
Pageof 26
The Journal of Clinical Psychiatry|November 19, 2008
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind studyMauricio Tohen, Eduard Vieta, Guy M Goodwin, et al.
The Lancet. Psychiatry|February 20, 2026
A digital imagery-competing task intervention for stopping intrusive memories in trauma-exposed health-care staff during the COVID-19 pandemic in the UK: a Bayesian adaptive randomised clinical trialAmy C Beckenstrom, Michael B Bonsall, Alfred Markham, et al.
Trials|March 4, 2016
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trialKate E A Saunders, Andrea Cipriani, Jennifer Rendell, et al.
Depression and Anxiety|July 30, 2020
Efficacy of digital cognitive behavioral therapy for moderate-to-severe symptoms of generalized anxiety disorder: A randomized controlled trialJenna R Carl, Christopher B Miller, Alasdair L Henry, et al.
Molecular Psychiatry|May 15, 2020
Patient fibroblast circadian rhythms predict lithium sensitivity in bipolar disorderHarshmeena R Sanghani, Aarti Jagannath, Thomas Humberstone, et al.
Bipolar Disorders|July 24, 2009
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disordersMauricio Tohen, Ellen Frank, Charles L Bowden, et al.
Trials|November 25, 2017
The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trialJonathan Kingslake, Rebecca Dias, Gerard R Dawson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 27, 2021
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trialMichael Browning, Amy C Bilderbeck, Rebecca Dias, et al.
Journal of Affective Disorders|March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Nature Reviews. Drug Discovery|February 2, 2012
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapyMark J Millan, Yves Agid, Martin Brüne, et al.
Pageof 26